1762 — Chunghwa Chemical Synthesis & Biotech Co Share Price
0.000.00%
Last trade - 00:00- TWD3.30bn
- TWD4.09bn
- TWD2.09bn
- 50
- 38
- 32
- 31
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.98 | ||
| Price to Tang. Book | 0.99 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.19 | ||
| EV to EBITDA | 14.89 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.91% | ||
| Return on Equity | 3.53% | ||
| Operating Margin | 5.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 1,156.64 | 1,543.59 | 1,934.7 | 2,117.14 | 2,086.44 | 1,730 | n/a | 15.4% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +238.83 | +111.81 | +61.56 | +16.11 | -42.91 | -21 | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of biotechnology products and chemical synthetic products. The Company's biotechnology products include pravastatin, rapamycin, tacrolimus, everolimus, mycophenolate mofetil, mycophenolic acid sodium and others. Its non-biotechnology products include methocarbamol, guaifenesin, trandolapril, fluconazole, olopatadine, dexbromopheniramine maleate and glipizide, among others. Its products are applied in the manufacture of drugs for treatment of cough, diabetes, cardiovascular diseases, high blood pressure and immune system diseases. The Company distributes its products within domestic market and to overseas markets, including the rest of Asia, the Americas and Europe.
Directors
- Yi-Zhen Wang Xie CHM
- Chung-Hsin Huang GMG
- Ying-Chi Chen DGM
- Qing-Peng Wei DGM
- Guo-Xian Zeng DGM
- Kuan-Chieh Wang OTH
- Yin-Nan Sun DRC
- Hou-Jie Wang DRC
- Chih-Hsien Chang IND
- Cheng-Hsien Tsai IND
- Kuo-Chiang Wang IND
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- May 19th, 1964
- Public Since
- December 10th, 2009
- No. of Shareholders
- 37,669
- No. of Employees
- 243
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 77,560,000
- Address
- No.1, Tung-Hsing Street, Shulin District, NEW TAIPEI, 238
- Web
- http://www.ccsb.com.tw
- Phone
- +886 286843318
- Auditors
- PricewaterhouseCoopers
Upcoming Events for 1762
Q4 2024 Chunghwa Chemical Synthesis & Biotech Co Ltd Earnings Release
Similar to 1762
Adimmune
Taiwan Stock Exchange
Bora Pharmaceuticals Co
Taiwan Stock Exchange
Cenra
Taiwan Stock Exchange
Formosa Laboratories
Taiwan Stock Exchange
Formosa Pharmaceuticals
Taiwan Stock Exchange
FAQ
What is the Chunghwa Chemical Synthesis & Biotech Co share price?
As of Today at 20:25 UTC, shares in Chunghwa Chemical Synthesis & Biotech Co are trading at TWD42.50. This share price information is delayed by 15 minutes.
How has the Chunghwa Chemical Synthesis & Biotech Co share price performed this year?
Shares in Chunghwa Chemical Synthesis & Biotech Co last closed at TWD42.50 and the price had moved by -31.23% over the past 365 days. In terms of relative price strength the Chunghwa Chemical Synthesis & Biotech Co share price has underperformed the FTSE Developed Asia Pacific Index by -35.85% over the past year.
What are the analyst and broker recommendations for Chunghwa Chemical Synthesis & Biotech Co?
The overall consensus recommendation for Chunghwa Chemical Synthesis & Biotech Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Chunghwa Chemical Synthesis & Biotech Co dividend yield?
The Chunghwa Chemical Synthesis & Biotech Co dividend yield is 1.88% based on the trailing twelve month period.
Does Chunghwa Chemical Synthesis & Biotech Co pay a dividend?
Last year, Chunghwa Chemical Synthesis & Biotech Co paid a total dividend of TWD0.80, and it currently has a trailing dividend yield of 1.88%. We do not have any data on when Chunghwa Chemical Synthesis & Biotech Co is to next pay dividends.
When does Chunghwa Chemical Synthesis & Biotech Co next pay dividends?
We do not have data on when Chunghwa Chemical Synthesis & Biotech Co is to next pay dividends. The historic dividend yield on Chunghwa Chemical Synthesis & Biotech Co shares is currently 1.88%.
How do I buy Chunghwa Chemical Synthesis & Biotech Co shares?
To buy shares in Chunghwa Chemical Synthesis & Biotech Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Chunghwa Chemical Synthesis & Biotech Co?
As of the previous close price of TWD42.50, shares in Chunghwa Chemical Synthesis & Biotech Co had a market capitalisation of TWD3.30bn.
Where are Chunghwa Chemical Synthesis & Biotech Co shares listed?
Here are the trading details for Chunghwa Chemical Synthesis & Biotech Co:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 1762
What kind of share is Chunghwa Chemical Synthesis & Biotech Co?
Based on an overall assessment of its quality, value and momentum Chunghwa Chemical Synthesis & Biotech Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Chunghwa Chemical Synthesis & Biotech Co share price forecast for 2024?
The analyst consensus target price for shares in Chunghwa Chemical Synthesis & Biotech Co is TWD125.00. That is 194.12% above the last closing price of TWD42.50.
Analysts covering Chunghwa Chemical Synthesis & Biotech Co currently have a consensus Earnings Per Share (EPS) forecast of TWD2.68 for the next financial year.
Find out moreWhat is the trend in the Chunghwa Chemical Synthesis & Biotech Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chunghwa Chemical Synthesis & Biotech Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -17.32%.
As of the last closing price of TWD42.50, shares in Chunghwa Chemical Synthesis & Biotech Co were trading -15.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Chunghwa Chemical Synthesis & Biotech Co PE Ratio?
The Chunghwa Chemical Synthesis & Biotech Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD42.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Chunghwa Chemical Synthesis & Biotech Co?
Chunghwa Chemical Synthesis & Biotech Co's management team is headed by:
- Yi-Zhen Wang Xie - CHM
- Chung-Hsin Huang - GMG
- Ying-Chi Chen - DGM
- Qing-Peng Wei - DGM
- Guo-Xian Zeng - DGM
- Kuan-Chieh Wang - OTH
- Yin-Nan Sun - DRC
- Hou-Jie Wang - DRC
- Chih-Hsien Chang - IND
- Cheng-Hsien Tsai - IND
- Kuo-Chiang Wang - IND